Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease.

Priti GrosXuesong WangJun GuanAnthony E LangPeter C AustinBlayne WelkNaomi P Visanji Connie Marras

Published in: Movement disorders : official journal of the Movement Disorder Society (2021)

Increasing exposure to phosphoglycerate kinase 1 activators and tamsulosin were both associated with small reductions in PD incidence. These results support further investigation of phosphoglycerate kinase 1 activators and tamsulosin for possible PD disease-modifying properties. © 2021 International Parkinson and Movement Disorder Society.

Keyphrases

protein kinase
risk factors
tyrosine kinase
benign prostatic hyperplasia
lower urinary tract symptoms